APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $17.4M invested in Aptevo Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.21M
2
+$815K

Top Sellers

1
-$946K
2
-$622K
3
-$408K
4
FM
Fondren Management
Texas
-$330K
5
TCIM
TIAA CREF Investment Management
New York
-$310K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$3K
52
$3K
53
$1K
54
$1K
55
$1K
56
$1K
57
$1K
58
$677
59
$658
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4